These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9894005)

  • 1. Crystal structures of rat thymidylate synthase inhibited by Tomudex, a potent anticancer drug.
    Sotelo-Mundo RR; Ciesla J; Dzik JM; Rode W; Maley F; Maley GF; Hardy LW; Montfort WR
    Biochemistry; 1999 Jan; 38(3):1087-94. PubMed ID: 9894005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.
    Almog R; Waddling CA; Maley F; Maley GF; Van Roey P
    Protein Sci; 2001 May; 10(5):988-96. PubMed ID: 11316879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.
    Phan J; Koli S; Minor W; Dunlap RB; Berger SH; Lebioda L
    Biochemistry; 2001 Feb; 40(7):1897-902. PubMed ID: 11329255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partitioning roles of side chains in affinity, orientation, and catalysis with structures for mutant complexes: asparagine-229 in thymidylate synthase.
    Finer-Moore JS; Liu L; Schafmeister CE; Birdsall DL; Mau T; Santi DV; Stroud RM
    Biochemistry; 1996 Apr; 35(16):5125-36. PubMed ID: 8611496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity.
    Rutenber EE; Stroud RM
    Structure; 1996 Nov; 4(11):1317-24. PubMed ID: 8939755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of strain in a stereospecific catalytic mechanism: crystal structures of Escherichia coli thymidylate synthase bound to FdUMP and methylenetetrahydrofolate.
    Hyatt DC; Maley F; Montfort WR
    Biochemistry; 1997 Apr; 36(15):4585-94. PubMed ID: 9109668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of thymidylate synthase mutant R166Q: structural basis for the nearly complete loss of catalytic activity.
    Sotelo-Mundo RR; Changchien L; Maley F; Montfort WR
    J Biochem Mol Toxicol; 2006; 20(2):88-92. PubMed ID: 16615077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-targeted antifolates aimed at avoiding drug resistance form covalent closed inhibitory complexes with human and Escherichia coli thymidylate synthases.
    Sayre PH; Finer-Moore JS; Fritz TA; Biermann D; Gates SB; MacKellar WC; Patel VF; Stroud RM
    J Mol Biol; 2001 Nov; 313(4):813-29. PubMed ID: 11697906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-resistant variants of Escherichia coli thymidylate synthase: effects of substitutions at Pro-254.
    Fantz C; Shaw D; Jennings W; Forsthoefel A; Kitchens M; Phan J; Minor W; Lebioda L; Berger FG; Spencer HT
    Mol Pharmacol; 2000 Feb; 57(2):359-66. PubMed ID: 10648646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D221 in thymidylate synthase controls conformation change, and thereby opening of the imidazolidine.
    Sage CR; Michelitsch MD; Stout TJ; Biermann D; Nissen R; Finer-Moore J; Stroud RM
    Biochemistry; 1998 Sep; 37(39):13893-901. PubMed ID: 9753479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition.
    Finer-Moore JS; Anderson AC; O'Neil RH; Costi MP; Ferrari S; Krucinski J; Stroud RM
    Acta Crystallogr D Biol Crystallogr; 2005 Oct; 61(Pt 10):1320-34. PubMed ID: 16204883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An essential role for water in an enzyme reaction mechanism: the crystal structure of the thymidylate synthase mutant E58Q.
    Sage CR; Rutenber EE; Stout TJ; Stroud RM
    Biochemistry; 1996 Dec; 35(50):16270-81. PubMed ID: 8973201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.
    Anderson AC; Perry KM; Freymann DM; Stroud RM
    J Mol Biol; 2000 Mar; 297(3):645-57. PubMed ID: 10731418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells.
    Aherne GW; Hardcastle A; Raynaud F; Jackman AL
    Biochem Pharmacol; 1996 May; 51(10):1293-301. PubMed ID: 8787544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 5-substitution in the pyrimidine ring of dUMP on the interaction with thymidylate synthase: molecular modeling and QSAR.
    Jarmuła A; Cieplak P; Krygowski TM; Rode W
    Bioorg Med Chem; 2007 Mar; 15(6):2346-58. PubMed ID: 17275316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic stabilization of nucleotide binding to thymidylate synthase by a potent benzoquinazoline folate analogue inhibitor.
    Chen CH; Davis RA; Maley F
    Biochemistry; 1996 Jul; 35(26):8786-93. PubMed ID: 8679643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic scheme for thymidylate synthase from Escherichia coli: determination from measurements of ligand binding, primary and secondary isotope effects, and pre-steady-state catalysis.
    Spencer HT; Villafranca JE; Appleman JR
    Biochemistry; 1997 Apr; 36(14):4212-22. PubMed ID: 9100016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of substituted diphenyl sulfones and sulfoxides as lipophilic inhibitors of thymidylate synthase.
    Jones TR; Webber SE; Varney MD; Reddy MR; Lewis KK; Kathardekar V; Mazdiyasni H; Deal J; Nguyen D; Welsh KM; Webber S; Johnston A; Matthews DA; Smith WW; Janson CA; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Bartlett CA; Morse CA
    J Med Chem; 1997 Feb; 40(5):677-83. PubMed ID: 9057854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural aspects of the inhibition and catalytic mechanism of thymidylate synthase.
    Hardy LW
    Acta Biochim Pol; 1995; 42(4):367-80. PubMed ID: 8852328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.